Myeloma Investment Fund is a new, independent, self-sustaining venture fund.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Myeloma Investment Fund is a new, independent, self-sustaining venture fund.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2022 | Triumvira Immunologics | Series A | 0 |
3/2021 | Fortis Therapeutics | Series A | 0 |
2/2022 | Indapta Therapeutics | Series A | 0 |
11/2022 | KAHR medical | Venture Round | 12.5M |
3/2022 | Triumvira Immunologics | Series A | 0 |
2/2022 | Indapta Therapeutics | Series A | 0 |
3/2021 | Fortis Therapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|